Idiopathic aplastic anemia (AA) is an immune-mediated and serious form of bone marrow failure. Akin to other autoimmune diseases, we have previously shown that in AA regulatory T cells (Tregs) are reduced in numberand function. The aim of this studywasto further characterize Treg subpopulations in AA and investigate the potential correlation between specific Treg subsets and response to immunosuppressive therapy (IST) as well as their in vitro expandability for potential clinical use. Using mass cytometry and an unbiased multidimensional analytical approach, we identified 2 specific human Treg subpopulations (Treg A and Treg B) with distinct phenotypes, gene expression, expandability, and function. Treg B predominates in IST responder patients, has a memory/activated phenotype (with higher expression of CD95, CCR4, and CD45RO within FOXP3hi, CD127lo Tregs), expresses the interleukin-2 (IL-2)/STAT5 pathway and cell-cycle commitment genes. Furthermore, in vitro-expanded Tregs become functional and take on the characteristics of Treg B. Collectively, this study identifies human Treg subpopulations that can be used as predictive biomarkers for response to IST in AA and potentially other autoimmune diseases. We also show that Tregs from AA patients are IL-2-sensitive and expandable in vitro, suggesting novel therapeutic approaches such as low-dose IL-2 therapy and/or expanded autologous Tregs and meriting further exploration.
Deep phenotyping of tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatment / Kordasti, S.; Costantini, B.; Seidl, T.; Abellan, P. P.; Llordella, M. M.; Mclornan, D.; Diggins, K. E.; Kulasekararaj, A.; Benfatto, C.; Feng, X.; Smith, A.; Mian, S. A.; Melchiotti, R.; De Rinaldis, E.; Ellis, R.; Petrov, N.; Povoleri, G. A. M.; Chung, S. S.; Thomas, N. S. B.; Farzaneh, F.; Irish, J. M.; Heck, S.; Young, N. S.; Marsh, J. C. W.; Mufti, G. J.. - In: BLOOD. - ISSN 0006-4971. - ELETTRONICO. - 128:9(2016), pp. 1193-1205. [10.1182/blood-2016-03-703702]
Deep phenotyping of tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatment
Kordasti S.Primo
Writing – Original Draft Preparation
;Costantini B.;
2016-01-01
Abstract
Idiopathic aplastic anemia (AA) is an immune-mediated and serious form of bone marrow failure. Akin to other autoimmune diseases, we have previously shown that in AA regulatory T cells (Tregs) are reduced in numberand function. The aim of this studywasto further characterize Treg subpopulations in AA and investigate the potential correlation between specific Treg subsets and response to immunosuppressive therapy (IST) as well as their in vitro expandability for potential clinical use. Using mass cytometry and an unbiased multidimensional analytical approach, we identified 2 specific human Treg subpopulations (Treg A and Treg B) with distinct phenotypes, gene expression, expandability, and function. Treg B predominates in IST responder patients, has a memory/activated phenotype (with higher expression of CD95, CCR4, and CD45RO within FOXP3hi, CD127lo Tregs), expresses the interleukin-2 (IL-2)/STAT5 pathway and cell-cycle commitment genes. Furthermore, in vitro-expanded Tregs become functional and take on the characteristics of Treg B. Collectively, this study identifies human Treg subpopulations that can be used as predictive biomarkers for response to IST in AA and potentially other autoimmune diseases. We also show that Tregs from AA patients are IL-2-sensitive and expandable in vitro, suggesting novel therapeutic approaches such as low-dose IL-2 therapy and/or expanded autologous Tregs and meriting further exploration.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
